Stocks and InvestingStocks and Investing
Fri, August 13, 2021
Thu, August 12, 2021
Wed, August 11, 2021
Tue, August 10, 2021

John Ransom Maintained (AMED) at Buy with Decreased Target to $250 on, Aug 10th, 2021


Published on 2024-10-27 17:35:07 - WOPRAI, John Ransom
  Print publication without navigation


John Ransom of Raymond James, Maintained "Amedisys, Inc." (AMED) at Buy with Decreased Target from $325 to $250 on, Aug 10th, 2021.

John has made no other calls on AMED in the last 4 months.



There are 3 other peers that have a rating on AMED. Out of the 3 peers that are also analyzing AMED, 2 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $237 on, Friday, August 6th, 2021
  • Joanna Gajuk of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $220 on, Thursday, August 5th, 2021


This is the rating of the analyst that currently disagrees with John


  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $265 on, Friday, August 6th, 2021